Clearside Biomedical (CLSD) Short Interest Ratio & Short Volume → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free CLSD Stock Alerts $1.25 -0.10 (-7.41%) (As of 05/10/2024 08:54 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Clearside Biomedical Short Interest DataCurrent Short Volume338,700 sharesPrevious Short Volume265,300 sharesChange Vs. Previous Month+27.67%Dollar Volume Sold Short$426,762.00Short Interest Ratio / Days to Cover0.9Last Record DateApril 30, 2024Outstanding Shares74,720,000 sharesPercentage of Shares Shorted0.45%Today's Trading Volume286,300 sharesAverage Trading Volume315,151 sharesToday's Volume Vs. Average91% Short Selling Clearside Biomedical ? Sign up to receive the latest short interest report for Clearside Biomedical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCLSD Short Interest Over TimeCLSD Days to Cover Over TimeCLSD Percentage of Float Shorted Over Time Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. Clearside Biomedical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024338,700 shares $426,762.00 +27.7%N/A0.9 $1.26 4/15/2024265,300 shares $342,237.00 +18.3%N/A0.7 $1.29 3/31/2024224,300 shares $343,179.00 -34.0%N/A0.6 $1.53 3/15/2024339,900 shares $581,229.00 +23.4%N/A1 $1.71 2/29/2024275,400 shares $385,560.00 +70.1%N/A1 $1.40 2/15/2024161,900 shares $197,518.00 -12.0%N/A0.9 $1.22 Get the Latest News and Ratings for CLSD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Clearside Biomedical and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024183,900 shares $229,875.00 -12.8%0.4%1 $1.25 1/15/2024210,800 shares $305,660.00 +11.1%0.4%1.1 $1.45 12/31/2023189,700 shares $221,949.00 -43.8%0.4%1 $1.17 12/15/2023337,700 shares $347,831.00 +19.4%0.7%2.1 $1.03 11/30/2023282,900 shares $285,729.00 -3.4%0.6%2.3 $1.01 11/15/2023292,900 shares $281,184.00 +0.8%0.6%2.5 $0.96 10/31/2023290,600 shares $210,568.76 -15.7%0.6%2.3 $0.72 10/15/2023344,500 shares $296,614.50 -1.7%0.7%3.6 $0.86 9/30/2023350,500 shares $304,899.95 -8.5%0.7%3.3 $0.87 9/15/2023382,900 shares $315,892.50 +45.4%0.8%3.4 $0.83 8/31/2023263,400 shares $239,694.00 +20.2%0.5%2.1 $0.91 8/15/2023219,200 shares $217,008.00 -17.5%0.4%1.8 $0.99 7/31/2023265,700 shares $310,869.00 -22.4%0.5%2.2 $1.17 7/15/2023342,400 shares $410,880.00 -17.4%0.7%2.7 $1.20 6/30/2023414,400 shares $464,128.00 -15.0%0.8%3.3 $1.12 6/15/2023487,600 shares $682,640.00 -22.1%1.0%2.9 $1.40 5/31/2023626,100 shares $676,188.00 +10.2%1.2%3.6 $1.08 5/15/2023568,400 shares $608,188.00 +102.8%1.1%3.1 $1.07 4/30/2023280,300 shares $283,103.00 +4.0%0.6%1.5 $1.01 4/15/2023269,600 shares $296,560.00 -19.6%0.5%1.3 $1.10 3/31/2023335,500 shares $348,920.00 -4.5%0.7%1.5 $1.04 3/15/2023351,200 shares $344,176.00 +8.7%0.7%1.5 $0.98 2/28/2023323,100 shares $400,644.00 +0.1%0.7%1.4 $1.24 2/15/2023322,700 shares $432,418.00 +30.5%0.7%1.3 $1.34 1/31/2023247,200 shares $348,552.00 +15.4%0.5%0.8 $1.41 1/15/2023214,300 shares $336,451.00 -48.3%0.4%0.8 $1.57 12/30/2022414,600 shares $464,352.00 +3.8%0.8%1.6 $1.12 12/15/2022399,500 shares $483,395.00 +5.9%0.8%1.8 $1.21 11/30/2022377,100 shares $456,291.00 -32.6%0.8%2 $1.21 11/15/2022559,600 shares $789,036.00 +4.8%1.2%3 $1.41 10/31/2022534,100 shares $608,874.00 +7.7%1.1%4.1 $1.14 10/15/2022495,800 shares $565,212.00 +4.8%1.0%3.9 $1.14 9/30/2022473,100 shares $534,603.00 -9.1%1.0%3.6 $1.13 9/15/2022520,300 shares $686,796.00 +11.0%1.1%3.8 $1.32Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. CLSD Short Interest - Frequently Asked Questions What is Clearside Biomedical's current short interest? Short interest is the volume of Clearside Biomedical shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 338,700 shares of CLSD short. Learn More on Clearside Biomedical's current short interest. What is a good short interest ratio for Clearside Biomedical? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLSD shares currently have a short interest ratio of 1.0. Learn More on Clearside Biomedical's short interest ratio. Which institutional investors are shorting Clearside Biomedical? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Clearside Biomedical: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Clearside Biomedical's short interest increasing or decreasing? Clearside Biomedical saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 338,700 shares, an increase of 27.7% from the previous total of 265,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Clearside Biomedical's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Clearside Biomedical: Eton Pharmaceuticals, Inc. (0.36%), Aclaris Therapeutics, Inc. (8.35%), Oramed Pharmaceuticals Inc. (0.80%), Anixa Biosciences, Inc. (2.08%), Milestone Pharmaceuticals Inc. (0.81%), Adagene Inc. (0.04%), BeyondSpring Inc. (9.99%), ProPhase Labs, Inc. (1.88%), IO Biotech, Inc. (0.10%), Oncolytics Biotech Inc. (1.14%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Clearside Biomedical stock? Short selling CLSD is an investing strategy that aims to generate trading profit from Clearside Biomedical as its price is falling. CLSD shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Clearside Biomedical? A short squeeze for Clearside Biomedical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CLSD, which in turn drives the price of the stock up even further. How often is Clearside Biomedical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLSD, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Eton Pharmaceuticals Short Squeeze Aclaris Therapeutics Short Squeeze Oramed Pharmaceuticals Short Squeeze Anixa Biosciences Short Squeeze Milestone Pharmaceuticals Short Squeeze Adagene Short Squeeze BeyondSpring Short Squeeze ProPhase Labs Short Squeeze IO Biotech Short Squeeze Oncolytics Biotech Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CLSD) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaCharles Payne Demystifies OptionsUnstoppable ProsperityElon’s New Device is About to Shock the WorldInvestorPlaceThe A.I. story nobody is telling you (Read ASAP)TradeSmithElon to Transform U.S. Economy? Porter & CompanyBill Clinton Backing Biden Replacement???The Freeport Society